Tags

Type your tag names separated by a space and hit enter

Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA.

Abstract

A new collagen-based MANTA vascular closure device (VCD) was developed for closing large-bore arteriotomies after transfemoral transcatheter aortic valve implantation (TAVI). We evaluated safety and feasibility at 30-day follow-up in terms of vascular and bleeding complications and mortality of the collagen-based MANTA VCD compared with the suture-based Prostar XL VCD in a cohort of 366 patients who underwent transfemoral TAVI between January 2015 and April 2018. The MANTA VCD was used in 168 patients and the Prostar XL VCD in 198 patients, with successful closure of 98.8% and 98.5%, respectively. VARC-2 defined as major vascular and bleeding complications was similar in both groups (MANTA vs Prostar XL): 0.6% versus 1.0% (p = 0.661) and 0.6% versus 1.5% (p = 0.102). Minor vascular and bleeding complications, were significantly more frequent (10.7 vs 18.8 %, p = 0.003 and 13.7 vs 19.7%, p = 0.080, respectively) in the Prostar XL cohort. Thirty-day all-cause mortality was 2.7%, without significant difference between the groups (p = 0.278). The MANTA device is a safe and feasible option for vascular access closure in patients undergoing transfemoral TAVI.

Authors+Show Affiliations

Interventional Cardiology Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands; Interventional Cardiology Unit, Puerta del Mar Hospital, Cadiz, Spain. Electronic address: livia_gheorghe_ro@yahoo.es.Interventional Cardiology Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Interventional Cardiology Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Interventional Cardiology Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Interventional Cardiology Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Cardiac Imaging Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Interventional Cardiology Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Cardiothoracic Surgery Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Cardiothoracic Surgery Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Cardiothoracic Surgery Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Interventional Cardiology Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.Interventional Cardiology Unit, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31443900

Citation

Gheorghe, Livia, et al. "Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA." The American Journal of Cardiology, 2019.
Gheorghe L, Brouwer J, Mathijssen H, et al. Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA. Am J Cardiol. 2019.
Gheorghe, L., Brouwer, J., Mathijssen, H., Nijenhuis, V. J., Rensing, B. J., Swaans, M. J., ... Ten Berg, J. M. (2019). Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA. The American Journal of Cardiology, doi:10.1016/j.amjcard.2019.07.030.
Gheorghe L, et al. Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA. Am J Cardiol. 2019 Jul 29; PubMed PMID: 31443900.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA. AU - Gheorghe,Livia, AU - Brouwer,Jorn, AU - Mathijssen,Harold, AU - Nijenhuis,Vincent J, AU - Rensing,Benno Jwm, AU - Swaans,Martin J, AU - Chan Pin Yin,Dean Rpp, AU - Heijmen,Robin H, AU - De Kroon,Tom, AU - Sonker,Uday, AU - Van der Heyden,Jan As, AU - Ten Berg,Jurrien M, Y1 - 2019/07/29/ PY - 2019/02/24/received PY - 2019/06/26/revised PY - 2019/07/02/accepted PY - 2019/8/25/entrez JF - The American journal of cardiology JO - Am. J. Cardiol. N2 - A new collagen-based MANTA vascular closure device (VCD) was developed for closing large-bore arteriotomies after transfemoral transcatheter aortic valve implantation (TAVI). We evaluated safety and feasibility at 30-day follow-up in terms of vascular and bleeding complications and mortality of the collagen-based MANTA VCD compared with the suture-based Prostar XL VCD in a cohort of 366 patients who underwent transfemoral TAVI between January 2015 and April 2018. The MANTA VCD was used in 168 patients and the Prostar XL VCD in 198 patients, with successful closure of 98.8% and 98.5%, respectively. VARC-2 defined as major vascular and bleeding complications was similar in both groups (MANTA vs Prostar XL): 0.6% versus 1.0% (p = 0.661) and 0.6% versus 1.5% (p = 0.102). Minor vascular and bleeding complications, were significantly more frequent (10.7 vs 18.8 %, p = 0.003 and 13.7 vs 19.7%, p = 0.080, respectively) in the Prostar XL cohort. Thirty-day all-cause mortality was 2.7%, without significant difference between the groups (p = 0.278). The MANTA device is a safe and feasible option for vascular access closure in patients undergoing transfemoral TAVI. SN - 1879-1913 UR - https://www.unboundmedicine.com/medline/citation/31443900/Early_Outcomes_After_Percutaneous_Closure_of_Access_Site_in_Transfemoral_Transcatheter_Valve_Implantation_Using_the_Novel_Vascular_Closure_Device_Collagen_Plug-Based_MANTA L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9149(19)30830-6 DB - PRIME DP - Unbound Medicine ER -